NIH-funded research R01 grant

Characterization of Shigella’s injection system and how it activates

Official title: Characterization of assembly and activation of the Shigella type III secretion injectisome

Funded at University of Missouri-Columbia · NIH-11386554 · Data updated 2026-11-12

A study to understand how the Shigella bacteria activates its special needle-like system to infect cells, using advanced imaging to reveal details that could lead to better prevention and treatment for children.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startAugust 1, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$616,769
NIH project number5R01AI172097-05
Project IDNIH-11386554 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be children in communities affected by Shigella infections or those at risk for severe diarrheal disease.

Less likely to help

Individuals not affected by Shigella infection or whose disease does not involve the injected mechanisms are unlikely to benefit directly.

What this research studies

Researchers will examine the Shigella type III secretion system (T3SS) in detail, focusing on how the secretion injectisome switches between active and inactive states. They will combine cryo-electron tomography with biochemical analyses to map the assembly and function of the cytoplasmic sorting platform and its interaction with the host membrane. The work aims to visualize the injectisome at near-atomic resolution and build models of how proteins rearrange during infection. Although conducted in a lab setting, the findings target insights that could inform strategies to prevent childhood diarrheal disease caused by Shigella.

Why it matters

Potential benefit: This research could contribute to future strategies to prevent or treat Shigella infections in children by interrupting the secretion system.

How similar studies have gone: Previous studies using cryo-ET have successfully visualized similar bacterial secretion systems, supporting the feasibility of this approach.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Picking, William D. — University of Missouri-Columbia
  • Study coordinator: Picking, William D.

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.